You Position: Home > Paper
Temozolomide plus rituximab in the treatment of recurrent central nervous system lymphoma:Case report and literature review
( views:358, downloads:36 )
- Author:
- No author available
- Journal Title:
- CHINESE-GERMAN JOURNAL OF CLINICAL ONCOLOGY
- Issue:
- 12
- DOI:
- 10.1007/s10330-009-0127-2
- Key Word:
- recurrent;primary central nervous system lymphoma;temozolomide;rituximab;treatment
Abstract： No abstract available
- [1]Ferreri AJ,Villa E,Reni M.Second-line treatment for primary central nervous system lymphoma.[J].1999,79(3).
- [2]Demopoulos A,DeAngelis LM,Enting RH,etc.Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide.[J].2004,63(5).
- [3]Eghbali H,Le-Mevel A,Blay JY,etc.High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.[J].1998,16(3).
- [4]Nelson DF.Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL).[J].1999,43(3).
- [5]Abrey LE,Hochman J,Zucca E,etc.Summary statement on primary central nervous system lymphomas from the eighth international conference on malignant lymphoma, lugano, Switzerland, june 12 to 15, 2002.[J].2003,21(12).
- [6]M, Reni,A J, Ferreri.Therapeutic management of refractory or relapsed primary central nervous system lymphomas.[J].2001,80 Suppl 3.